Gianfranco Catalano

Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia

Adriano Venditti, Francesco Buccisano, Giovanni Del Poeta et al. · Blood · 2000 · 242 citations

Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia

Adriano Venditti, Francesco Buccisano, Giovanni Del Poeta et al. · Blood · 2000 · 217 citations

Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells.

David Adams, Liana Harvath, Donald P. Bottaro et al. · Proceedings of the National Academy of Sciences · 1994 · 127 citations · Full text

Cell Adhesion, Immunology, T Cells +19

Pyrrolo[1,2-<i>b</i>][1,2,5]benzothiadiazepines (PBTDs):  A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant

Romano Silvestri, Gabriella Marfè, Marino Artico et al. · Journal of Medicinal Chemistry · 2006 · 57 citations · Full text

Chemoprevention Strategy, Apoptosis, Cell Death +19

High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts <i>in vitro</i>

Nélida I. Noguera, Elvira Pelosi, Daniela F. Angelini et al. · Oncotarget · 2017 · 54 citations · Full text